Celgosivir: Phase II data

In an open-label Phase II trial in 57 patients, celgosivir plus pegylated peginterferon alfa-2b and ribavirin

Read the full 166 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE